Kenvue reports $3.89B 1Q earnings, beats analyst expectations, and announces a 4% workforce reduction.
Kenvue, the consumer health company known for brands like Tylenol and Band-Aid, reported first-quarter earnings of $3.89B, beating analyst expectations. The company announced a 4% workforce reduction in light of expiring services for Johnson & Johnson. Kenvue aims to achieve $350M in annual pre-tax gross savings by 2026 through cost-cutting measures while incurring $275M in restructuring expenses in 2024 and 2025.
May 07, 2024
6 Articles